國立高雄大學圖資館 |

Nanotechnology based strategies for cancer immunotherapyconcepts, design, and clinical applications /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Nanotechnology based strategies for cancer immunotherapyedited by Rajeev Sharma, Vikas Pandey, Neeraj Mishra.
其他題名:	concepts, design, and clinical applications /
其他作者:	Sharma, Rajeev.
出版者:	Singapore :Springer Nature Singapore :2024.
面頁冊數:	xviii, 492 p. :ill., digital ;24 cm.
Contained By:	Springer Nature eBook
標題:	CancerImmunotherapy.
電子資源:	https://doi.org/10.1007/978-981-97-7022-9
ISBN:	9789819770229$q(electronic bk.)

Nanotechnology based strategies for cancer immunotherapyconcepts, design, and clinical applications /
Nanotechnology based strategies for cancer immunotherapyconcepts, design, and clinical applications /[electronic resource] :edited by Rajeev Sharma, Vikas Pandey, Neeraj Mishra. - Singapore :Springer Nature Singapore :2024. - xviii, 492 p. :ill., digital ;24 cm.

Introduction to cancer immunotherapy -- Therapeutic hallmark of cancer & immunology -- Novel immunotherapeutic approaches for cancer therapy -- Recent advances in bio material for Immunotherapeutic applications -- Combination therapies for the management of cancer immunotherapy -- Cancer Vaccines as Immunotherapeutic frontier -- Dendritic Cell based approaches in cancer immunotherapy -- Peptides based Vaccines in cancer immunotherapy -- Monoclonal antibodies based nanobiotechnology based approaches in cancer immunotherapy -- Chimeric Antigen Receptor T Cells Based Cancer Immunotherapy -- Polymer and lipid based nanocomplexes in cancer immunotherapy -- Role of the tumor microenvironment in cancer immunotherapy -- Inorganic nanoparticles based strategies for Cancer Immunotherapy -- POLYMERIC NANOPARTICLES BASED STRATEGIES FOR CANCER IMMUNOTHERAPY -- Advances in Lipid-based nanosystem for immune induction in cancer immunotherapy -- Design, implementation and interpretation of clinical trials of cancer immunotherapy -- Ethical considerations of cancer immunotherapy, and patient perspectives on the benefits and risks of treatment -- REGULATORY ASPECTS OF CANCER IMMUNOTHERAPY -- Clinical applications, Patents and challenges in cancer immunotherapy.

This book will give an up-to-date and thorough exposition of the state of the art of concepts, design, and recent advances in nanobiotechnology-based strategies for cancer Immunotherapy, and their current and clinical status. Nanobiotechnology-based Targeted therapies and Immunotherapy have been added to the effective oncologic treatment and have become increasingly popular in oncology. It is intended to enable the researchers to prepare a variety of Nanobiotechnology-based strategies, investigate their properties, and discover their uses and applications in cancer immunotherapy. The novelty of the approach is to address an existing need to understand exhaustively the potential of the nanotechnology-based approaches, including targeted and smartly designed therapies, that deliver loaded immunoreactive (s) into the body at predefined sites. The book will also discuss the patents related to cancer immunotherapy. Because of the versatility and wide range of properties, nanobiotechnology-based systems are extensively used in cancer immunotherapy. The task of obtaining a versatile candidate in immune component(s) delivery seems to be intricated, as it has to surpass several vigorous clinical barriers. As a result, many scientists rely on nanobiotechnology-based approaches, which have already been approved and well-established. Over the years, extensive research has been undertaken on the delivery of immunoreactive(s) using nanotechnology-based delivery systems. With advancements in nanobiotechnology, more needs are realized to develop nanoengineered/smart delivery systems with even more convoluted properties. Currently, research is mainly focused on nanoengineered systems, which can perform one or more of the desired functions. The proposed book summarizes the basic principles and research supporting cancer immunotherapy clinical translation contains nanobiotechnology-based treatment strategies for all immunotherapy classes and agents, including cell-based therapies, monoclonal antibodies, cytokine therapies, checkpoint inhibitors, oncolytic viruses, adjuvant approaches, treatment combinations Includes information on all FDA-approved immunotherapies, for individual cancer types, including melanoma and other skin cancers, lung cancers, gastrointestinal cancers, hematologic cancers, genitourinary cancers, head and neck cancers, sarcomas, brain cancers, and breast cancer etc. Also explains the regulatory aspects behind the development and approval of immunotherapy drugs.

ISBN: 9789819770229$q(electronic bk.)

Standard No.: 10.1007/978-981-97-7022-9doiSubjects--Topical Terms:

201873
Cancer
--Immunotherapy.

LC Class. No.: RC271.I45

Dewey Class. No.: 616.994061

Nanotechnology based strategies for cancer immunotherapyconcepts, design, and clinical applications /
LDR:04824nmm a2200325 a 4500 001 674954
003 DE-He213
005 20250207115241.0
006 m d
007 cr nn 008maaau
008 250624s2024 si s 0 eng d
020 $a 9789819770229$q(electronic bk.)
020 $a 9789819770212$q(paper)
024 7 $a 10.1007/978-981-97-7022-9 $2 doi
035 $a 978-981-97-7022-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC271.I45
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
072 7 $a MJCL $2 thema
082 0 4 $a 616.994061 $2 23
090 $a RC271.I45 $b N186 2024
245 0 0 $a Nanotechnology based strategies for cancer immunotherapy $h [electronic resource] : $b concepts, design, and clinical applications / $c edited by Rajeev Sharma, Vikas Pandey, Neeraj Mishra.
260 $a Singapore : $b Springer Nature Singapore : $b Imprint: Springer, $c 2024.
300 $a xviii, 492 p. : $b ill., digital ; $c 24 cm.
505 0 $a Introduction to cancer immunotherapy -- Therapeutic hallmark of cancer & immunology -- Novel immunotherapeutic approaches for cancer therapy -- Recent advances in bio material for Immunotherapeutic applications -- Combination therapies for the management of cancer immunotherapy -- Cancer Vaccines as Immunotherapeutic frontier -- Dendritic Cell based approaches in cancer immunotherapy -- Peptides based Vaccines in cancer immunotherapy -- Monoclonal antibodies based nanobiotechnology based approaches in cancer immunotherapy -- Chimeric Antigen Receptor T Cells Based Cancer Immunotherapy -- Polymer and lipid based nanocomplexes in cancer immunotherapy -- Role of the tumor microenvironment in cancer immunotherapy -- Inorganic nanoparticles based strategies for Cancer Immunotherapy -- POLYMERIC NANOPARTICLES BASED STRATEGIES FOR CANCER IMMUNOTHERAPY -- Advances in Lipid-based nanosystem for immune induction in cancer immunotherapy -- Design, implementation and interpretation of clinical trials of cancer immunotherapy -- Ethical considerations of cancer immunotherapy, and patient perspectives on the benefits and risks of treatment -- REGULATORY ASPECTS OF CANCER IMMUNOTHERAPY -- Clinical applications, Patents and challenges in cancer immunotherapy.
520 $a This book will give an up-to-date and thorough exposition of the state of the art of concepts, design, and recent advances in nanobiotechnology-based strategies for cancer Immunotherapy, and their current and clinical status. Nanobiotechnology-based Targeted therapies and Immunotherapy have been added to the effective oncologic treatment and have become increasingly popular in oncology. It is intended to enable the researchers to prepare a variety of Nanobiotechnology-based strategies, investigate their properties, and discover their uses and applications in cancer immunotherapy. The novelty of the approach is to address an existing need to understand exhaustively the potential of the nanotechnology-based approaches, including targeted and smartly designed therapies, that deliver loaded immunoreactive (s) into the body at predefined sites. The book will also discuss the patents related to cancer immunotherapy. Because of the versatility and wide range of properties, nanobiotechnology-based systems are extensively used in cancer immunotherapy. The task of obtaining a versatile candidate in immune component(s) delivery seems to be intricated, as it has to surpass several vigorous clinical barriers. As a result, many scientists rely on nanobiotechnology-based approaches, which have already been approved and well-established. Over the years, extensive research has been undertaken on the delivery of immunoreactive(s) using nanotechnology-based delivery systems. With advancements in nanobiotechnology, more needs are realized to develop nanoengineered/smart delivery systems with even more convoluted properties. Currently, research is mainly focused on nanoengineered systems, which can perform one or more of the desired functions. The proposed book summarizes the basic principles and research supporting cancer immunotherapy clinical translation contains nanobiotechnology-based treatment strategies for all immunotherapy classes and agents, including cell-based therapies, monoclonal antibodies, cytokine therapies, checkpoint inhibitors, oncolytic viruses, adjuvant approaches, treatment combinations Includes information on all FDA-approved immunotherapies, for individual cancer types, including melanoma and other skin cancers, lung cancers, gastrointestinal cancers, hematologic cancers, genitourinary cancers, head and neck cancers, sarcomas, brain cancers, and breast cancer etc. Also explains the regulatory aspects behind the development and approval of immunotherapy drugs.
650 0 $a Cancer $x Immunotherapy. $3 201873
650 0 $a Nanomedicine. $3 273406
650 1 4 $a Cancer Nanotechnology. $3 911846
650 2 4 $a Cancer Therapy. $3 915060
650 2 4 $a Immunotherapy. $3 211033
650 2 4 $a Tumour Immunology. $3 921116
700 1 $a Sharma, Rajeev. $3 988775
700 1 $a Pandey, Vikas. $3 964422
700 1 $a Mishra, Neeraj. $3 949458
710 2 $a SpringerLink (Online service) $3 273601
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-981-97-7022-9
950 $a Medicine (SpringerNature-11650)